SPRO

Spero Therapeutics Inc

Jun 17 • 04:00PM ET

2.11

-0.66 -23.83 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AGEN CNTB GALT IMUX KZIA VRCA MOLN HURA ORMP PLX

| Held by: VTI VXF DFMC DFAS QQQS AVSC DFAT PRFZ DCOR DFAC

Scroll to Statements

Index	-	P/E	8.66	EPS (ttm)	0.24	Insider Own	25.86%	Shs Outstand	57.89M	Perf Week	-16.93%
Market Cap	122.17M	Forward P/E	2.78	EPS next Y	0.76	Insider Trans	-1.30%	Shs Float	42.93M	Perf Month	-18.22%
Enterprise Value	68.51M	PEG	-	EPS next Q	-	Inst Own	14.47%	Short Float	3.98%	Perf Quarter	-14.23%
Income	15.23M	P/S	2.23	EPS this Y	346.67%	Inst Trans	-1.55%	Short Ratio	2.81	Perf Half Y	-7.86%
Sales	54.77M	P/B	2.31	EPS next Y	13.43%	ROA	22.28%	Short Interest	1.71M	Perf YTD	-9.44%
Book/sh	0.91	P/C	2.18	EPS next 5Y	-	ROE	35.12%	52W High	3.22 -34.47%	Perf Year	-27.24%
Cash/sh	0.97	P/FCF	16.87	EPS past 3/5Y	- -	ROIC	28.51%	52W Low	1.80 17.22%	Perf 3Y	35.26%
Dividend Est.	-	EV/EBITDA	8.83	Sales past 3/5Y	7.06% 197.00%	Gross Margin	-	Volatility	17.14% 8.77%	Perf 5Y	-86.09%
Dividend TTM	-	EV/Sales	1.25	EPS Y/Y TTM	121.50%	Oper. Margin	14.16%	ATR (14)	0.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.50	Sales Y/Y TTM	93.50%	Profit Margin	27.82%	RSI (14)	32.92	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.50	EPS Q/Q	49.76%	SMA20	-23.34%	Beta	1.46	Target Price	4.00
Payout	0.00%	Debt/Eq	0.05	Sales Q/Q	-94.95%	SMA50	-21.57%	Rel Volume	18.10	Prev Close	2.77
Employees	25	LT Debt/Eq	0.01	Earnings	May 13 AMC	SMA200	-12.00%	Avg Volume	607.08K	Price	2.11
IPO	Nov 02, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	10,990,762	Change	-23.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)